The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma

1. Puig, N.
2. Sarasquete, M.E.
3. Alcoceba, M.
4. Balanzategui, A.
5. Chillón, M.C.
6. Sebastián, E.
7. Marín, L.A.
8. Díaz, M.G.
9. San Miguel, J.F.
10. Sanz, R.G.